Diffusion and Diffusion Tensor Imaging in Brain Cancer

Seminars in Radiation Oncology

Volumn 21, Issue 2, 2011, Pages 141-146

  Gerstner, Elizabeth R ^a   Sorensen, A Gregory ^b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEDIRANIB;

BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT; TREATMENT PLANNING; TREATMENT RESPONSE;

BRAIN; BRAIN MAPPING; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; HUMANS;

EID: 79952016080     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.10.005     Document Type: Review

References (37)

1. Gerstner E.R., Frosch M.P., Batchelor T.T. Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab. J Clin Oncol 2010, 28:e91-e93.
2. Ellingson B.M., Malkin M.G., Rand S.D., et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010, 31:538-548.
3. Sadeghi N., D'Haene N., Decaestecker C., et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: Relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008, 29:476-482.
4. Seierstad T., Roe K., Olsen D.R. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model. Radiother Oncol 2007, 85:187-194.
5. Higano S., Yun X., Kumabe T., et al. Malignant astrocytic tumors: Clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006, 241:839-846.
6. Liu Y., Bai R., Sun H., et al. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 2009, 64:1067-1074.
7. Kim S., Loevner L., Quon H., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009, 15:986-994.
8. Razek A.A., Gaballa G., Denewer A., et al. Invasive ductal carcinoma: Correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 2010, 23:619-623.
9. Murakami R., Sugahara T., Nakamura H., et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: Prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007, 243:493-499.
10. deSouza N.M., Riches S.F., Vanas N.J., et al. Diffusion-weighted magnetic resonance imaging: A potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008, 63:774-782.
11. Kajihara H., Hayashida Y., Murakami R., et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys 2009, 74:399-403.
12. Dirix P., Vandecaveye V., De Keyzer F., et al. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: Impact on radiotherapy planning. Int J Radiat Oncol Biol Phys 2010, 76:761-766.
13. Eccles C.L., Haider E.A., Haider M.A., et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations. Acta Oncol 2009, 48:1034-1043.
14. Rhee T.K., Naik N.K., Deng J., et al. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: Comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol 2008, 19:1180-1186.
15. Tomura N., Narita K., Izumi J., et al. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: Possible prediction of treatment response. J Comput Assist Tomogr 2006, 30:496-500.
16. Mardor Y., Pfeffer R., Spiegelmann R., et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003, 21:1094-1100.
17. Hamstra D.A., Galbán C.J., Meyer C.R., et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival. J Clin Oncol 2008, 26:3387-3394.
18. Sun Y.S., Zhang X.P., Tang L., et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010, 254:170-178.
19. Kim S.H., Lee J.M., Hong S.H., et al. Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009, 253:116-125.
20. Harry V.N., Semple S.I., Gilbert F.J., et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008, 111:213-220.
21. Dirix P., Vandecaveye V., De Keyzer F., et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: Value of repeated functional imaging with (18)F-FDG PET, p 18F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 2009, 50:1020-1027.
22. Yoshida S., Koga F., Kawakami S., et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 2010, 75:387-391.
23. Haris M., Kumar S., Raj M.K., et al. Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas. Radiat Med 2008, 26:140-150.
24. Welzel T., Niethammer A., Mende U., et al. Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: First results of a prospective study. AJNR Am J Neuroradiol 2008, 29:379-383.
25. Leung L.H., Ooi G.C., Kwong D.L., et al. White-matter diffusion anisotropy after chemo-irradiation: A statistical parametric mapping study and histogram analysis. Neuroimage 2004, 21:261-268.
26. Khong P.L., Kwong D.L., Chan G.C., et al. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: A pilot study. AJNR Am J Neuroradiol 2003, 24:734-740.
27. Qiu D., Kwong D.L., Chan G.C., et al. Diffusion tensor magnetic resonance imaging finding of discrepant fractional anisotropy between the frontal and parietal lobes after whole-brain irradiation in childhood medulloblastoma survivors: Reflection of regional white matter radiosensitivity?. Int J Radiat Oncol Biol Phys 2007, 69:846-851.
28. Kim C.K., Park B.K., Park W., et al. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: Preliminary experience. Abdom Imaging 2010, 35:246-252.
29. Gerstner E.R., Chen P.J., Wen P.Y., et al. Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib. Neuro Oncol 2010, 12:466-472.
30. Asao C., Korogi Y., Kitajima M., et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 2005, 26:1455-1460.
31. Goldman M., Boxerman J.L., Rogg J.M., et al. Utility of apparent diffusion coefficient in predicting the outcome of gamma knife-treated brain metastases prior to changes in tumor volume: A preliminary study. J Neurosurg 2006, 105(suppl):175-182.
32. Abdel Razek A.A., Kandeel A.Y., Soliman N., et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007, 28:1146-1152.
33. Vandecaveye V., De Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo-)radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007, 67:960-971.
34. Rock J.P., Scarpace L., Hearshen D., et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004, 54:1111-1117.
35. Galban C.J., Mukherji S.K., Chenevert T.L., et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009, 2:184-190.
36. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005, 102:5524-5529.
37. Hamstra D.A., Chenevert T.L., Moffat B.A., et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005, 102:16759-16764.